12-128414770-T-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001136103.3(TMEM132C):c.124T>A(p.Phe42Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000455 in 1,538,146 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001136103.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM132C | NM_001136103.3 | c.124T>A | p.Phe42Ile | missense_variant | 2/9 | ENST00000435159.3 | NP_001129575.2 | |
TMEM132C | NM_001387058.1 | c.64T>A | p.Phe22Ile | missense_variant | 2/9 | NP_001373987.1 | ||
TMEM132C | XM_047429886.1 | c.124T>A | p.Phe42Ile | missense_variant | 2/9 | XP_047285842.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM132C | ENST00000435159.3 | c.124T>A | p.Phe42Ile | missense_variant | 2/9 | 5 | NM_001136103.3 | ENSP00000410852.2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152092Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000289 AC: 4AN: 1386054Hom.: 0 Cov.: 30 AF XY: 0.00000146 AC XY: 1AN XY: 683848
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152092Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74292
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 05, 2024 | The c.124T>A (p.F42I) alteration is located in exon 2 (coding exon 2) of the TMEM132C gene. This alteration results from a T to A substitution at nucleotide position 124, causing the phenylalanine (F) at amino acid position 42 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at